MyFinsight
Home
Blog
About
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Return on Equity
-8,232.292
-28,840.749
-1,405.797
-33,370.837
Debt to Asset Ratio
8.583
31.601
28.688
26.821
Cash Ratio
404.08
215.432
122.55
338.221
Quick Ratio
1,930.582
765.799
813.648
1,428.073
Current Ratio
1,930.582
765.799
813.648
1,428.073
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.